DelveInsight's Oncolytic Virus Competitive Landscape 2026 report provides comprehensive global coverage of pipeline oncolytic ...

The "Decentralized Clinical Trials Market - Global Forecast 2026-2032" report has been added to ResearchAndMarkets.com's ...

AstraZeneca's $15 billion pledge to its China operations highlights the country's advantages. But other regions are also hoping to host more clinical studies.

Forbes contributors publish independent expert analyses and insights. Tor Constantino is an ex-reporter, turned AI consultant & tech writer. Parexel's research found 6% of surveyed executives say ...

83% use email, portals, and paper to exchange information with study partners, slowing study execution and increasing risk of non-compliance Research reveals most medtech companies (83%) rely on ...

Early safety and visual performance signals were reported at 3 months from a first-in-human (FIH) clinical study evaluating ...

A groundbreaking multi-stakeholder report reveals that transitioning to Non-Animal Methods (NAMs) can reduce drug development ...

Cabaletta Bio, Inc. announced promising results from its ongoing RESET clinical trials for its investigational therapy rese-cel, focusing on autoimmune diseases. In the trials, notable outcomes ...

The "DNA Cancer Vaccine Clinical Trials, Development Technology Platforms & Market Opportunity Outlook 2026" report has been added to ResearchAndMarkets.com's offering. The global impact of cancer ...

The data showed a favourable safety and tolerability profile consistent with earlier Zoryve clinical trials.

Over recent decades, advances in cancer treatment have yielded substantial improvements in patient outcomes, driving up survival, and even rendering some cancers curable. These advances have been ...